1. Home
  2. MNPR vs WRN Comparison

MNPR vs WRN Comparison

Compare MNPR & WRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNPR
  • WRN
  • Stock Information
  • Founded
  • MNPR 2014
  • WRN 2006
  • Country
  • MNPR United States
  • WRN Canada
  • Employees
  • MNPR N/A
  • WRN N/A
  • Industry
  • MNPR Biotechnology: Pharmaceutical Preparations
  • WRN Metal Mining
  • Sector
  • MNPR Health Care
  • WRN Basic Materials
  • Exchange
  • MNPR Nasdaq
  • WRN Nasdaq
  • Market Cap
  • MNPR 248.8M
  • WRN 248.0M
  • IPO Year
  • MNPR 2019
  • WRN N/A
  • Fundamental
  • Price
  • MNPR $44.21
  • WRN $1.52
  • Analyst Decision
  • MNPR Strong Buy
  • WRN Strong Buy
  • Analyst Count
  • MNPR 10
  • WRN 1
  • Target Price
  • MNPR $66.56
  • WRN $4.00
  • AVG Volume (30 Days)
  • MNPR 38.8K
  • WRN 506.2K
  • Earning Date
  • MNPR 11-07-2025
  • WRN 11-06-2025
  • Dividend Yield
  • MNPR N/A
  • WRN N/A
  • EPS Growth
  • MNPR N/A
  • WRN N/A
  • EPS
  • MNPR N/A
  • WRN N/A
  • Revenue
  • MNPR N/A
  • WRN N/A
  • Revenue This Year
  • MNPR N/A
  • WRN N/A
  • Revenue Next Year
  • MNPR N/A
  • WRN N/A
  • P/E Ratio
  • MNPR N/A
  • WRN N/A
  • Revenue Growth
  • MNPR N/A
  • WRN N/A
  • 52 Week Low
  • MNPR $2.29
  • WRN $0.90
  • 52 Week High
  • MNPR $54.30
  • WRN $1.58
  • Technical
  • Relative Strength Index (RSI)
  • MNPR 65.29
  • WRN 69.78
  • Support Level
  • MNPR $32.77
  • WRN $1.45
  • Resistance Level
  • MNPR $36.49
  • WRN $1.58
  • Average True Range (ATR)
  • MNPR 2.93
  • WRN 0.06
  • MACD
  • MNPR 1.14
  • WRN 0.02
  • Stochastic Oscillator
  • MNPR 99.97
  • WRN 81.43

About MNPR Monopar Therapeutics Inc.

Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.

About WRN Western Copper and Gold Corporation

Western Copper & Gold Corp is a Canada-based exploration-stage company. The company is engaged in the exploration and development of the Casino mineral property located in Yukon, Canada (the Casino Project).

Share on Social Networks: